TY - JOUR
T1 - Transcatheter aortic valve implantation in patients with an extremely small native aortic annulus
T2 - The OCEAN-TAVI registry
AU - Yashima, Fumiaki
AU - Yamamoto, Masanori
AU - Tanaka, Makoto
AU - Yanagisawa, Ryo
AU - Arai, Takahide
AU - Shimizu, Hideyuki
AU - Fukuda, Keiichi
AU - Watanabe, Yusuke
AU - Naganuma, Toru
AU - Shirai, Shinichi
AU - Araki, Motoharu
AU - Tada, Norio
AU - Yamanaka, Futoshi
AU - Hayashida, Kentaro
N1 - Publisher Copyright:
© 2017 Elsevier B.V.
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Background Transcatheter aortic valve implantation (TAVI) has been reported to be advantageous over surgical aortic valve replacement owing to the low incidence of prosthesis-patient mismatch (PPM) and large effective orifice area (EOA). However, data on TAVI for extremely small annuli are limited. The present study aimed to compare post-procedural hemodynamics and morphology between 20-mm and 23-mm Sapien XT (SXT) transcatheter heart valves (THVs) with extremely small annuli (< 314 mm2). Methods All patients with severe aortic stenosis treated with TAVI at eight Japanese centers between October 2013 and January 2016 were prospectively included in the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry. In the overall cohort of 20-mm (19 patients) and 23-mm SXTs (492 patients) with extremely small annuli, the patient groups were matched one-to-one using propensity scores, and post-procedural echocardiography and multidetector computed tomography data were compared for 18 matched patients from each group (matched cohort). Results In the matched cohort, the mean gradient was higher (15.4 ± 4.1 vs. 12.2 ± 4.8 mm Hg, p = 0.04), EOA was lower (1.22 ± 0.25 vs. 1.44 ± 0.37 cm2, p = 0.02) and THV area was lower (245.6 ± 19.1 vs. 298.5 ± 33.3 mm2, p < 0.01) in the 20-mm group than in the 23-mm group. However, all patients in both groups were asymptomatic. Although moderate PPM was more prevalent in the 20-mm group than in the 23-mm group (31.6% vs. 7.9%, p < 0.01), the incidence of severe PPM was low and similar between the groups (0% vs. 0.4%, p = 1.00) in the overall cohort. Conclusion A 20-mm SXT in patients who require a small bioprosthesis leads to favorable short-term outcomes.
AB - Background Transcatheter aortic valve implantation (TAVI) has been reported to be advantageous over surgical aortic valve replacement owing to the low incidence of prosthesis-patient mismatch (PPM) and large effective orifice area (EOA). However, data on TAVI for extremely small annuli are limited. The present study aimed to compare post-procedural hemodynamics and morphology between 20-mm and 23-mm Sapien XT (SXT) transcatheter heart valves (THVs) with extremely small annuli (< 314 mm2). Methods All patients with severe aortic stenosis treated with TAVI at eight Japanese centers between October 2013 and January 2016 were prospectively included in the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry. In the overall cohort of 20-mm (19 patients) and 23-mm SXTs (492 patients) with extremely small annuli, the patient groups were matched one-to-one using propensity scores, and post-procedural echocardiography and multidetector computed tomography data were compared for 18 matched patients from each group (matched cohort). Results In the matched cohort, the mean gradient was higher (15.4 ± 4.1 vs. 12.2 ± 4.8 mm Hg, p = 0.04), EOA was lower (1.22 ± 0.25 vs. 1.44 ± 0.37 cm2, p = 0.02) and THV area was lower (245.6 ± 19.1 vs. 298.5 ± 33.3 mm2, p < 0.01) in the 20-mm group than in the 23-mm group. However, all patients in both groups were asymptomatic. Although moderate PPM was more prevalent in the 20-mm group than in the 23-mm group (31.6% vs. 7.9%, p < 0.01), the incidence of severe PPM was low and similar between the groups (0% vs. 0.4%, p = 1.00) in the overall cohort. Conclusion A 20-mm SXT in patients who require a small bioprosthesis leads to favorable short-term outcomes.
KW - Aortic stenosis
KW - Prosthesis-patient mismatch
KW - Small annulus
KW - Transcatheter aortic valve implantation
UR - http://www.scopus.com/inward/record.url?scp=85020457082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020457082&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2017.01.076
DO - 10.1016/j.ijcard.2017.01.076
M3 - Article
C2 - 28606674
AN - SCOPUS:85020457082
SN - 0167-5273
VL - 240
SP - 126
EP - 131
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -